» Articles » PMID: 30422905

Brief Report: Body Mass Index and Cognitive Function Among HIV-1-Infected Individuals in China, India, and Nigeria

Abstract

Background: Risk of cognitive impairment is increased among persons with high or low body mass index in HIV- and HIV+ populations in resource-rich settings. We examined this association among HIV+ patients in 3 resource-limited settings.

Methods: This secondary analysis included data of 761 HIV+ volunteers pooled from 3 prospective cohort studies conducted in China (n = 404; 53%), India (n = 200; 26%), and Nigeria (n = 157; 21%). World Health Organization (WHO) weight classifications were based on body mass index. T scores, adjusted for demographics and practice effects, were derived from a 7-domain neuropsychological battery. Neurocognitive impairment (NCI) was defined as global deficit score of ≥0.5.

Results: Overall, prevalence of NCI at baseline was 27.7% (similar across all cohorts). The overweight/obese and underweight constituted 37.3% and 15.5% of the total participants, respectively. In a multivariable logistic regression of pooled longitudinal data, adjusting for clinical and demographic variables, the odds of global NCI were 38% higher among the overweight/obese as compared to normal weight participants [odds ratio: 1.38 (95% confidence interval: 1.1 to 1.72); P = 0.005]. Similarly, the odds of global NCI were 39% higher among the underweight as compared to normal weight participants [odds ratio: 1.39 (95% confidence interval: 1.03 to 1.87); P = 0.029].

Conclusions: NCI among HIV-1-infected patients was more prevalent in both overweight/obese and underweight than normal weight individuals in 3 resource-limited settings, confirming observations in resource-rich settings. Mechanisms underlying these associations are unclear but likely differ for underweight and overweight persons.

Citing Articles

Neuroimaging advances in neurocognitive disorders among HIV-infected individuals.

Wang H, Jiu X, Wang Z, Zhang Y Front Neurol. 2025; 16:1479183.

PMID: 40017532 PMC: 11864956. DOI: 10.3389/fneur.2025.1479183.


Prevalence and characteristics of metabolic syndrome and its components among adults living with and without HIV in Nigeria: a single-center study.

Jumare J, Dakum P, Sam-Agudu N, Memiah P, Nowak R, Bada F BMC Endocr Disord. 2023; 23(1):160.

PMID: 37507703 PMC: 10375691. DOI: 10.1186/s12902-023-01419-x.


Inflammatory profile associated with insulin resistance in non-overweight versus overweight people living with HIV in Pune, Western India.

Chebrolu P, Sangle S, Nimkar S, Salvi S, Chavan A, Kulkarni V Diabetes Metab Syndr. 2022; 16(7):102551.

PMID: 35777254 PMC: 9912190. DOI: 10.1016/j.dsx.2022.102551.


Psychosocial Factors Associated with Suicidal Ideation Among HIV/AIDS Patients on Follow-Up at Dessie Referral Hospital, Northeast Ethiopia: A Cross-Sectional Study.

Tamirat K, Tesema G, Tessema Z HIV AIDS (Auckl). 2021; 13:415-423.

PMID: 33883949 PMC: 8055467. DOI: 10.2147/HIV.S299538.


Neuroimaging and Cognitive Evidence for Combined HIV-Alcohol Effects on the Central Nervous System: A Review.

Britton M, Porges E, Bryant V, Cohen R Alcohol Clin Exp Res. 2020; 45(2):290-306.

PMID: 33296091 PMC: 9486759. DOI: 10.1111/acer.14530.


References
1.
McCutchan J, Marquie-Beck J, Fitzsimons C, Letendre S, Ellis R, Heaton R . Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology. 2012; 78(7):485-92. PMC: 3280051. DOI: 10.1212/WNL.0b013e3182478d64. View

2.
Paz-Filho G, Wong M, Licinio J . The procognitive effects of leptin in the brain and their clinical implications. Int J Clin Pract. 2010; 64(13):1808-12. PMC: 2998704. DOI: 10.1111/j.1742-1241.2010.02536.x. View

3.
Yaffe K, Kanaya A, Lindquist K, Simonsick E, Harris T, Shorr R . The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA. 2004; 292(18):2237-42. DOI: 10.1001/jama.292.18.2237. View

4.
Wolf P, Beiser A, Elias M, Au R, Vasan R, Seshadri S . Relation of obesity to cognitive function: importance of central obesity and synergistic influence of concomitant hypertension. The Framingham Heart Study. Curr Alzheimer Res. 2007; 4(2):111-6. DOI: 10.2174/156720507780362263. View

5.
Dahl A, Hassing L, Fransson E, Berg S, Gatz M, Reynolds C . Being overweight in midlife is associated with lower cognitive ability and steeper cognitive decline in late life. J Gerontol A Biol Sci Med Sci. 2009; 65(1):57-62. PMC: 2796876. DOI: 10.1093/gerona/glp035. View